UBS Group Initiates Coverage on Summit Therapeutics (NASDAQ:SMMT)
Stock analysts at UBS Group started coverage on shares of Summit Therapeutics (NASDAQ:SMMT – Get Free Report) in a research note issued on Tuesday, MarketBeat Ratings reports. The brokerage set a “buy” rating and a $30.00 price target on the stock. UBS Group’s target price indicates a potential upside of 32.63% from the stock’s previous […]
More Stories
The Gentlemen Season 2 is Airing: Know About the Plot, Episodes, and Cast
Eddie has returned with season 2 of The Gentlemen. This time, his appearance and costumes reflect his new life as...
LEGO ONE PIECE is Live! Where to Watch and Full Cast Updates
Good news for Straw Hats fans who were waiting for the release of LEGO ONE PIECE Season 3. No, its...
Rebel Moon 3: Release Date, Cast Members, and Production Details
Zack Snyder has finally spoken about the release of Rebel Moon 3 after the release of the second sequel in...
Is Crew Girl Renewed for Season 2? Release Date, Cast, and Production Details
Are you also a fan of Canadian drama? Miku and Kyle’s duo is returning with Crew Girl Season 2. It...
The Four Seasons Season 3: Release Date, Cast, Episodes, and More
Looking for an upcoming American romantic-comedy drama series? Good news! The popular friendship-based series is coming back. The Four Seasons...
Take Charge of My Heart: Release Date, Trailer, Plot, and More
Are you also hunting for the next Korean romantic-comedy drama? Then your search ends here. Take Charge of My Heart...